- $1.49bn
- $1.11bn
- $22.04m
- 36
- 11
- 22
- 12
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0 | 2.1 | 11.1 | 22 |
Cost of Revenue | ||||
Gross Profit | — | 1.06 | 8.24 | 14.1 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Total Operating Expenses | 0.66 | 40.8 | 96.9 | 180 |
Operating Profit | -0.66 | -38.7 | -85.7 | -158 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -16.2 | -106 | -48.5 | -158 |
Provision for Income Taxes | ||||
Net Income After Taxes | -16.2 | -106 | -48.5 | -158 |
Net Income Before Extraordinary Items | ||||
Net Income | -16.2 | -106 | -48.5 | -158 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -16.2 | -106 | -48.5 | -158 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.436 | -0.772 | -0.245 | -0.779 |
Dividends per Share |